Concord Biotech Ltd. is all set to begin commercial production at its newly-built injectable facility in Ahmedabad by the end of March, according to Chief Executive Officer Ankur Vaid. "The facility has been undergoing validation tests for over six to eight months and will initially focus on supplying in the domestic market," he told Informist recently.
Share this Story:
